DiNAQOR

BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
Yahoo/PR Newswire
Sun, 05/3/20 - 07:53 pm
Biomarin
DiNAQOR
gene therapy
cardiomyopathy